Insights into tumor hypoxia: The Breast Cancer Oncogene EMSY increases the expression of FIH (Factor inhibiting Hypoxia inducible Factor) via down regulation of its target gene, 8/March/2014, 21.48

Squamous cell carcinoma: TAp63 suppresses the expression of FSCN1 via up regulation of its target gene, 8/March/2014, 21.31
March 8, 2014
Insights into the targeting of cancer progression: The Breast Cancer Oncogene EMSY increases the expression of SATB2 via down regulation of its target gene, 8/March/2014, 22.02
March 8, 2014
Show all

Prof. Dr Kouzarides and his co-workers from  Cancer Research Gurdon Institute, University of Cambridge, UK report in the prestigious journal Molecular Cell (2014) that The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31”  

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Insights into tumor hypoxia: The Breast Cancer Oncogene EMSY increases the expression of FIH (Factor inhibiting Hypoxia inducible Factor) via down regulation of its target gene.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Insights into tumor hypoxia: The Breast Cancer Oncogene EMSY increases the expression of FIH (Factor inhibiting Hypoxia inducible Factor) via down regulation of its target gene, 8/March/2014, 21.48,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

 

Comments are closed.